Stereotaxis (AMEX:STXS) Stock Quotes, Forecast and News Summary

Q: What sector and industry does Stereotaxis (STXS) operate in?

Stereotaxis is in the Health Care sector and Health Care Equipment & Supplies industry. They are listed on the AMEX.

Stereotaxis Stock (AMEX: STXS) stock price, news, charts, stock research, profile.

Open	$2.37
Close	$2.26
Volume / Avg.	580.59K / 308.74K
Day Range	$2.22 - $2.46
52 Wk Range	1.63 - 3.29
Market Cap	$200.81M
P/E Ratio	-
Dividend Yield	-
Exchange	AMEX
RSI	59
Short Interest	3.65%
Days to Cover	5.19

Recent News

AxoGen Q2 Earnings and Revenues Beat Estimates

AxoGen (NASDAQ: AXGN) came out with quarterly earnings of $0.05 per share, beating the Zacks Consensus Estimate of a loss of $0.05 per share. This compares to loss of $0.03 per share a year ago. These figures are adjusted for non-recurring items.

Zacks

Hyliion Holdings And 3 Other Penny Stocks Insiders Are Buying

Avi Kapoor

Insiders Buying Eyenovia And 3 Other Stocks Under $2

The Dow Jones closed lower by around 80 points on Tuesday. When insiders purchase or sell shares, it indicates their confidence or concern around the company's prospects. Investors and traders interested in penny stocks can consider this a factor in their overall investment or trading decision.

Lisa Levin

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Analyst Rating and Forecast

4.2

Buy

Strong Buy

Buy

Hold

Sell

Strong Sell

Open	$2.37
Close	$2.26
Volume / Avg.	580.59K / 308.74K
Day Range	$2.22 - $2.46
52 Wk Range	1.63 - 3.29
Market Cap	$200.81M
P/E Ratio	-
Dividend Yield	-
Exchange	AMEX
RSI	59
Short Interest	3.65%
Days to Cover	5.19

Compare

EPS worse than industry

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

EPS worse than industry

FAQ

How do I buy Stereotaxis (STXS) stock?

You can purchase shares of Stereotaxis (AMEX:STXS) through any online brokerage.

View our list of the best stock brokerages

Who are Stereotaxis (STXS) competitors?

Other companies in Stereotaxis’s space includes: NeuroPace (NASDAQ:NPCE), Pro-Dex (NASDAQ:PDEX), Sight Sciences (NASDAQ:SGHT), AngioDynamics (NASDAQ:ANGO) and Fractyl Health (NASDAQ:GUTS).

What is the forecast, or price target, for Stereotaxis (STXS) stock?

Stereotaxis has a consensus price target of $6.81.

What is the current price for Stereotaxis (STXS)?

The stock price for Stereotaxis (AMEX: STXS) is $2.37 last updated December 18, 2024 at 4:16 PM EST.

Does Stereotaxis (STXS) pay a dividend?

There are no upcoming dividends for Stereotaxis.

When is Stereotaxis (AMEX:STXS) reporting earnings?

Stereotaxis’s Q4 earnings are confirmed for Monday, March 3, 2025.

Is Stereotaxis (STXS) going to split?

There is no upcoming split for Stereotaxis.

What sector and industry does Stereotaxis (STXS) operate in?

Stereotaxis is in the Health Care sector and Health Care Equipment & Supplies industry. They are listed on the AMEX.

Comments

Stereotaxis

Stereotaxis (STXS) Forecast